These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 313841

  • 1. The adjuvant activity of synthetic N-acetylmuramyl-dipeptide: evidence of initial target cells for the adjuvant activity.
    Sugimura K, Uemiya M, Saiki I, Azuma I, Yamamura Y.
    Cell Immunol; 1979 Mar 01; 43(1):137-49. PubMed ID: 313841
    [No Abstract] [Full Text] [Related]

  • 2. Macrophage-stimulating effect of a synthetic muramyl dipeptide and its adjuvant-active and -inactive analogs for the production of T-cell activating monokines.
    Iribe H, Koga T, Onoue K, Kotani S, Kusumoto S, Shiba T.
    Cell Immunol; 1981 Oct 01; 64(1):73-83. PubMed ID: 7028277
    [No Abstract] [Full Text] [Related]

  • 3. Control of the mitogenicity of muramyl dipeptide.
    Wood DD, Staruch MJ.
    Int J Immunopharmacol; 1981 Oct 01; 3(1):31-44. PubMed ID: 6975247
    [No Abstract] [Full Text] [Related]

  • 4. In vivo regulation of humoral and cellular immune responses of mice by a synthetic adjuvant, N-acetyl-muramyl-L-alanyl-D-isoglutamine, muramyl dipeptide for MDP.
    Leclerc C, Juy D, Bourgeois E, Chedid L.
    Cell Immunol; 1979 Jun 01; 45(1):199-206. PubMed ID: 313275
    [No Abstract] [Full Text] [Related]

  • 5. Specific impaired alloreactivity of mice immunized with syngeneic MLCT-lymphoblasts using muramylpeptides as adjuvant.
    Binz H, Tarcsay L, Wigzell H, Dukor P.
    Transplant Proc; 1981 Mar 01; 13(1 Pt 1):566-73. PubMed ID: 6455801
    [No Abstract] [Full Text] [Related]

  • 6. Stimulation of the in vivo dinitrophenyl antibody response to the DNP conjugate of L-glutamic acid60-L-alanine30-L-Tyrosine10 (GAT) polymer by a synthetic adjuvant, muramyl dipeptide (MDP): target cells for adjuvant activity and isotypic pattern of MDP-stimulated response.
    Lowy I, Theze J, Chedid L.
    J Immunol; 1980 Jan 01; 124(1):100-4. PubMed ID: 6965289
    [Abstract] [Full Text] [Related]

  • 7. Adjuvant activity of mycoloyl derivatives of N-acetylmuramyl-L-alanyl-D-isoglutamine in mice and guinea pigs.
    Uemiya M, Saiki I, Kusama T, Azuma I, Yamamura Y.
    Microbiol Immunol; 1979 Jan 01; 23(8):821-3. PubMed ID: 120487
    [No Abstract] [Full Text] [Related]

  • 8. Apyrogenic synthetic desmuramyldipeptide, LK-409, with immunomodulatory properties.
    Sollner M, Kotnik V, Pecar S, Stace A, Simcic S, Povsic L, Herzog-Wraber B, Klampfer L, Ihan A, Grosman P.
    Agents Actions; 1993 Mar 01; 38(3-4):273-80. PubMed ID: 8213354
    [Abstract] [Full Text] [Related]

  • 9. The macrophage, target cell of the synthetic adjuvant muramyl dipeptide.
    Fevrier M, Birrien JL, Leclerc C, Chedid L, Liacopoulos P.
    Eur J Immunol; 1978 Aug 01; 8(8):558-62. PubMed ID: 359336
    [Abstract] [Full Text] [Related]

  • 10. Enhancement by muramyl dipeptide of in vitro nude mice responses to a T-dependent antigen.
    Leclerc C, Bourgeois E, Chedid L.
    Immunol Commun; 1979 Aug 01; 8(1):55-64. PubMed ID: 311334
    [Abstract] [Full Text] [Related]

  • 11. The in situ induction of tumoricidal activity in alveolar macrophages by liposomes containing muramyl dipeptide is a thymus-independent process.
    Fidler IJ.
    J Immunol; 1981 Oct 01; 127(4):1719-20. PubMed ID: 6974201
    [No Abstract] [Full Text] [Related]

  • 12. Enhancement of in vitro immune responses of murine Peyer's patch cultures by concanavalin A, muramyl dipeptide and lipopolysaccharide.
    Kiyono H, McGhee JR, Kearney JF, Michalek SM.
    Scand J Immunol; 1982 Apr 01; 15(4):329-39. PubMed ID: 7048508
    [No Abstract] [Full Text] [Related]

  • 13. N-[trans-2-[[2'-(acetylamino)cyclohexyl]oxy]acetyl]-L-alanyl-D-glutamic acid: a novel immunologically active carbocyclic muramyl dipeptide analogue.
    Kikelj D, Pecar S, Kotnik V, Stalc A, Wraber-Herzog B, Simcic S, Ihan A, Klamfer L, Povsic L, Grahek R, Suhadolc E, Hocevar M, Hönig H, Rogi-Kohlenprath R.
    J Med Chem; 1998 Feb 12; 41(4):530-9. PubMed ID: 9484503
    [Abstract] [Full Text] [Related]

  • 14. Target cells for the activity of a synthetic adjuvant: muramyl dipeptide.
    Löwy I, Bona C, Chedid L.
    Cell Immunol; 1977 Mar 01; 29(1):195-9. PubMed ID: 321136
    [No Abstract] [Full Text] [Related]

  • 15. Higher immunoadjuvant activities of N-acetyl-beta-D-glucosaminyl-(1-4)-N-acetylmuramyl-L-alanyl-D-isoglutamine in comparison with N-acetylmuramyl-L-alanyl-D-isoglutamine.
    Tsujimoto M, Kinoshita F, Okunaga T, Kotani S, Kusumoto S, Yamamoto K, Shiba T.
    Microbiol Immunol; 1979 Mar 01; 23(9):933-6. PubMed ID: 576117
    [No Abstract] [Full Text] [Related]

  • 16. Direct augmentation of cytolytic activity of tumor-derived macrophages and macrophage cell lines by muramyl dipeptide.
    Taniyama T, Holden HT.
    Cell Immunol; 1979 Dec 01; 48(2):369-74. PubMed ID: 228871
    [No Abstract] [Full Text] [Related]

  • 17. Adjuvant activity of synthetic 6-O-"mycoloyl"-N-acetylmuramyl-L-alanyl-D-isoglutamine and related compounds.
    Azuma I, Sugimura K, Yamawaki M, Uemiya M, Kusumoto S, Okada S, Shiba T, Yamamura Y.
    Infect Immun; 1978 Jun 01; 20(3):600-7. PubMed ID: 97234
    [Abstract] [Full Text] [Related]

  • 18. Augmentation of the proliferative response of thymocytes to phytohemagglutinin by the muramyl dipeptide1.
    Iribe H, Koga T.
    Cell Immunol; 1984 Oct 01; 88(1):9-15. PubMed ID: 6332683
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of mitogen-induced polyclonal activation by by a synthetic adjuvant, muramyl dipeptide (MDP).
    Löwy I, Leclerc C, Bourgeois E, Chedid L.
    J Immunol; 1980 Jan 01; 124(1):320-5. PubMed ID: 6985643
    [Abstract] [Full Text] [Related]

  • 20. Interleukin 1, a mediator of immunoadjuvant peptidoglycans.
    Guenounou M, Vacheron F, Nauciel C.
    Comp Immunol Microbiol Infect Dis; 1985 Jan 01; 8(3-4):273-84. PubMed ID: 2868825
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.